B4GALNT1 and head and neck squamous cell carcinoma: Furthermore, the expression level of B4GALNT1 had been examined in tumors including breast cancers [7], cervical cancers [14], head and neck squamous cell carcinoma [20], and clear cell renal cell carcinoma [6]; and the expression level was found to be higher than that in normal tissues, which matched the results of our study.